AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Navigating Spironolactone and Renal Outcomes
This chapter explores the role of spironolactone in treating heart failure and kidney disease, discussing its efficacy and the challenges posed by existing clinical trials. It highlights the importance of historical studies, such as RALS and TopCat, while emphasizing the need for more extensive studies to better capture renal outcomes. The conversation also addresses medication adherence and the implications of recent findings on potassium management in dialysis patients.